Icikinase - Recombinant Streptokinase 1.5 M IU Inj

Streptokinase belongs to a class of medications known as thrombolytics, or "clot busters," which work by activating a natural enzyme in the body called plasminogen, converting it into plasmin. Plasmin then acts to break down the fibrin mesh that holds blood clots together, helping dissolve clots that may be blocking blood flow. It is primarily used in the emergency treatment of acute myocardial infarction (heart attack), where prompt clot dissolution can help restore blood flow to the heart muscle and limit damage. It may also be used in certain cases of pulmonary embolism and other significant blood clot-related conditions. Because timing is critical in these situations, Streptokinase is typically administered as soon as possible after symptom onset, in a hospital or emergency care setting under close medical supervision. The medication is given through intravenous infusion, with the healthcare team closely monitoring the patient throughout administration for response and overall stability. Restoring blood flow promptly can significantly improve outcomes and support better recovery of heart function after a heart attack. Many patients treated with timely thrombolytic therapy experience improved clinical outcomes as part of comprehensive emergency cardiac care. As with all emergency thrombolytic therapies, Streptokinase should only be administered by experienced healthcare professionals in a properly equipped medical setting.